A nonprofit based in White Oak has plans to collaborate on regulations, science, and planned development with a state in southern India.
The IV2 Alliance Inc. and the state of Telangana, India, on Oct. 13 signed a memorandum of understanding, agreeing to explore opportunities to boost regulatory science and biomedical development.
The plan builds on an International Sister Cities agreement between Montgomery County and the city of Hyderabad, Telangana, which was established in 2014, noted Jonathan Genn, president of IV2, in a statement.
IV2 and the state of Telangana will promote the planned $3 billion, 300-acre Viva White Oak development of life sciences firms, housing and shops next to the Food and Drug Administration headquarters in Montgomery County. They will also promote the planned Hyderabad Pharma City, which is described in a report in The Times of India as a 12,500-acre site catering to the facilities requirements of pharmaceutical manufacturers in Hyderabad.
Both will also promote economic development, science, technology, commercial, and financial activities in Montgomery County and Telangana.
IV2 in 2013 signed a memorandum of understanding with the FDA to advance regulatory science and foster biomedical innovations, and to promote international harmonization in public health. That agreement notes that both IV2 and the FDA have a common interest in White Oak as an epicenter of science. The memorandum between IV2 and Telangana is in conjunction with the 2013 memo, according to IV2.
Genn is also executive vice president and general counsel of Global LifeSci Development Corp., an affiliate of IV2, which has a deal with Montgomery County to develop Viva White Oak.
Montgomery County’s economic development agency describes the development project as something that will drive the economy for eastern Montgomery County for generations.